We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYCHU
5676
DELISTED
Keyarch Acquisition Corporation Unit
KYCHU
$1K ﹤0.01%
99
MCAF
5677
DELISTED
Mountain Crest Acquisition Corp. IV Common Stock
MCAF
$1K ﹤0.01%
84
-52
-38% -$533
THWWW
5678
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
$1K ﹤0.01%
238
POL
5679
DELISTED
Polished.com Inc.
POL
$1K ﹤0.01%
33
-62
-65% -$1.96K
WRAC.U
5680
DELISTED
Williams Rowland Acquisition Corp. Units, each consisting of one share of common stock and one-half of one redeemable warrant
WRAC.U
$1K ﹤0.01%
100
ROI
5681
DELISTED
RiskOn International, Inc. Common Stock
ROI
$1K ﹤0.01%
397
-14
-3% -$104
SLACU
5682
DELISTED
Social Leverage Acquisition Corp I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
SLACU
$1K ﹤0.01%
53
CHIC
5683
DELISTED
Global X MSCI China Communication Services ETF
CHIC
$1K ﹤0.01%
35
CHEA
5684
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
$1K ﹤0.01%
141
+115
+442% +$1.2K
PTHRU
5685
DELISTED
Pono Capital Three, Inc. Unit
PTHRU
$1K ﹤0.01%
+78
New +$797
CSTA
5686
DELISTED
Constellation Acquisition Corp I
CSTA
$1K ﹤0.01%
136
-75
-36% -$765
SRT
5687
DELISTED
Startek Inc.
SRT
$1K ﹤0.01%
267
+237
+790% +$941
AMTI
5688
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$1K ﹤0.01%
3,939
-6,915
-64% -$3.61K
CLAYU
5689
DELISTED
Chavant Capital Acquisition Corp. Unit
CLAYU
$1K ﹤0.01%
98
IMPL
5690
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$1K ﹤0.01%
+1,038
New +$2.48K
TBCP
5691
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$1K ﹤0.01%
+101
New +$1K
TBCPU
5692
DELISTED
Thunder Bridge Capital Partners III Inc. Units
TBCPU
$1K ﹤0.01%
64
LIVB
5693
DELISTED
LIV Capital Acquisition Corp. II Class A Ordinary Shares
LIVB
$1K ﹤0.01%
67
-15
-18% -$155
VCXAU
5694
DELISTED
10X Capital Venture Acquisition Corp II Unit
VCXAU
$1K ﹤0.01%
113
-500
-82% -$5.04K
CZOO
5695
DELISTED
Cazoo Group Ltd
CZOO
$1K ﹤0.01%
+3
New +$977
CORR
5696
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$1K ﹤0.01%
745
-4,616
-86% -$7.9K
APGB.U
5697
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
$1K ﹤0.01%
125
ROSE
5698
DELISTED
Rose Hill Acquisition Corporation Class A Ordinary Shares
ROSE
$1K ﹤0.01%
100
-553
-85% -$5.78K
JGGC
5699
DELISTED
Jaguar Global Growth Corporation I Class A Ordinary Shares
JGGC
$1K ﹤0.01%
+100
New +$1.03K
ACER
5700
DELISTED
Acer Therapeutics Inc
ACER
$1K ﹤0.01%
910
-247
-21% -$487

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.